Blue Owl Capital (NYSE:OWL) Given New $17.00 Price Target at Evercore ISI

Blue Owl Capital (NYSE:OWL) had its price objective decreased by Evercore ISI from $19.00 to $17.00 in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. Evercore ISI currently has an outperform rating on the stock.

A number of other analysts have also recently weighed in on the stock. Wolfe Research set a $20.00 target price on shares of Blue Owl Capital in a report on Wednesday, January 7th. Piper Sandler cut their price objective on Blue Owl Capital from $23.50 to $22.00 and set an “overweight” rating for the company in a research report on Thursday, October 9th. Citigroup reissued a “market outperform” rating on shares of Blue Owl Capital in a research note on Tuesday, October 21st. BMO Capital Markets began coverage on Blue Owl Capital in a report on Friday, October 3rd. They issued an “outperform” rating and a $18.00 target price on the stock. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $16.25 target price on shares of Blue Owl Capital in a report on Tuesday, January 6th. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Blue Owl Capital presently has an average rating of “Moderate Buy” and an average target price of $20.78.

Blue Owl Capital Trading Down 0.6%

Shares of Blue Owl Capital stock opened at $15.67 on Thursday. Blue Owl Capital has a 52 week low of $13.25 and a 52 week high of $26.73. The stock has a market cap of $24.44 billion, a PE ratio of 261.21, a price-to-earnings-growth ratio of 1.34 and a beta of 1.13. The company’s 50-day moving average price is $15.34 and its two-hundred day moving average price is $17.08.

Blue Owl Capital (NYSE:OWL) last posted its quarterly earnings data on Thursday, October 30th. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $687.00 million during the quarter, compared to analyst estimates of $685.95 million. Blue Owl Capital had a net margin of 1.89% and a return on equity of 20.05%. On average, equities analysts predict that Blue Owl Capital will post 0.92 EPS for the current fiscal year.

Blue Owl Capital Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 24th. Stockholders of record on Monday, November 10th were issued a $0.225 dividend. The ex-dividend date was Monday, November 10th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 5.7%. Blue Owl Capital’s dividend payout ratio is presently 1,500.00%.

Insiders Place Their Bets

In other Blue Owl Capital news, insider Craig Packer acquired 110,227 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The stock was purchased at an average cost of $15.06 per share, for a total transaction of $1,660,018.62. Following the transaction, the insider owned 94,000 shares of the company’s stock, valued at $1,415,640. The trade was a -679.28% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Alan Kirshenbaum bought 33,670 shares of the stock in a transaction on Monday, December 1st. The shares were acquired at an average cost of $14.87 per share, for a total transaction of $500,672.90. Following the purchase, the chief financial officer owned 33,670 shares in the company, valued at approximately $500,672.90. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders acquired 395,670 shares of company stock worth $5,952,393. 27.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Blue Owl Capital

Hedge funds have recently made changes to their positions in the stock. Roxbury Financial LLC grew its position in Blue Owl Capital by 383.6% during the fourth quarter. Roxbury Financial LLC now owns 1,765 shares of the company’s stock valued at $26,000 after purchasing an additional 1,400 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Blue Owl Capital by 117.0% during the 3rd quarter. Parkside Financial Bank & Trust now owns 1,608 shares of the company’s stock valued at $27,000 after acquiring an additional 867 shares in the last quarter. Activest Wealth Management purchased a new position in shares of Blue Owl Capital during the 3rd quarter valued at $50,000. MorganRosel Wealth Management LLC acquired a new position in shares of Blue Owl Capital in the second quarter worth $51,000. Finally, Headlands Technologies LLC purchased a new stake in shares of Blue Owl Capital during the second quarter worth $51,000. 35.85% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Blue Owl Capital

Here are the key news stories impacting Blue Owl Capital this week:

• Neutral Sentiment: Evercore ISI lowered its price target on OWL from $19.00 to $17.00 but maintained an “outperform” rating — a mixed signal (reduced upside but continued analyst support). Blue Owl Capital price target lowered by Evercore ISI
• Negative Sentiment: Numerous plaintiff firms have announced class‑action filings or investigations alleging securities fraud and are soliciting lead plaintiffs for the class period noted above; they emphasize a Feb. 2, 2026 lead‑plaintiff filing deadline, increasing the likelihood of consolidated litigation and potential legal costs or settlements that could pressure the stock. Representative notices include Levi & Korsinsky, Rosen Law Firm, Glancy Prongay Wolke & Rotter, Bronstein Gewirtz & Grossman, Pomerantz, Faruqi & Faruqi and others.
  Levi & Korsinsky class action notice
  Rosen Law Firm deadline notice
  Glancy Prongay Wolke & Rotter notice
  Bronstein, Gewirtz & Grossman notice

Blue Owl Capital Company Profile

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.